Anticoagulant Therapy Clinical Trial
Official title:
Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic
This is an observational, prospective, multicenter, cohort study in patients with cardioembolic stroke and previous oral or parenteral anticoagulant therapy. Patients in which anticoagulante therapy is mantained will be compared to those in which it is interrupted, in terms of stroke or systemic embolism and haemorrhagic transformation.
Observational, prospective, multicenter, cohort study in patients with recent cardioembolic stroke (<24 hours) and previous oral or parenteral anticoagulant therapy (last dose recieved <24hours) . Patients in which anticoagulante therapy is mantained will be compared to those in which it is interrupted. The decision to mantain or interrumpt the anticoagulant therapy is made by the treating physician as hospital protocol. Stroke recurrence, haemorrhagic transformation at 90 days are evalauted and also complication during the hospitalization and functional outcome. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05300997 -
Translational Immunodiagnostics in Stroke (TrImS)
|
||
| Completed |
NCT02681042 -
Left Atrial Appendage Closure With SentreHeart Lariat® Device
|
N/A | |
| Recruiting |
NCT02742480 -
Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)
|
||
| Completed |
NCT02181361 -
Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation
|
||
| Not yet recruiting |
NCT06232278 -
Long-term Results of Percutaneous Left Atrial Closure at Brest University Hospital (CLAPOT)
|
||
| Completed |
NCT02014896 -
Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)
|
||
| Active, not recruiting |
NCT05498909 -
A Real-world Registry Study of Multidisciplinary Collaborative Diagnosis and Treatment Model for Cardioembolic Stroke
|
||
| Recruiting |
NCT03897478 -
Biomarkers of Acute Stroke in Clinic
|